机译:富含含亮的含重复的G蛋白质偶联受体5和CD133表达与低直肠癌癌症进展和术前化学疗法的肿瘤进展和抗性有关
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Hosp Dept Pathol Bunkyo Ku Tokyo 1138655 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
Univ Tokyo Fac Med Dept Surg Div Surg Oncol Bunkyo Ku 7-3-1 Hongo Tokyo 1138656 Japan;
LGR5; CD133; rectal cancer; chemoradiotherapy; immunohistochemistry;
机译:富含含亮的含重复的G蛋白质偶联受体5和CD133表达与低直肠癌癌症进展和术前化学疗法的肿瘤进展和抗性有关
机译:富含含亮的含重复的G蛋白质偶联受体5和CD133表达与低直肠癌癌症进展和术前化学疗法的肿瘤进展和抗性有关
机译:富含含亮的含重复的G蛋白质偶联受体5和CD133表达与低直肠癌癌症进展和术前化学疗法的肿瘤进展和抗性有关
机译:术前癌症治疗对ABY-029导向肉瘤手术中表皮生长因子受体(EGFR)受体表达水平的影响
机译:直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
机译:富含亮氨酸的重复序列包含G蛋白偶联受体5和CD133的表达与低位直肠癌的肿瘤进展和术前放化疗的耐药性相关
机译:富含亮氨酸的重复的G蛋白偶联受体5和CD133表达与肿瘤进展和对低直肠癌的术前化学疗法的抗性有关